Dr. Benedikt Luhmann is principal of VI Partners and co-founder & member of the executive board of Angels4Health. Prior to focusing on entrepreneurs and innovation, Benedikt build and grew a digital health start-up as COO, he provided advise as consultant of international strategy consultant firms (i.a. Boston Consulting Group) on product development and commercial strategy to medical device and pharmaceutical companies. In addition, he served as assistant to the management of a European hospital company and focused as scientist of a university hospital on oncology research. He is closely involved in many investments, like Inositec, Altoida, and iOnctura as well as completed transactions, like Amal Therapeutics. In addition, he serves pro bono on boards of various organizations such as OneBio.

Benedikt received a graduate (MD/ PhD) in medicine from the University of Kiel after studying medicine at the University of Kiel, University of Cape Town, Yale University and Harvard University. His PhD thesis addressed oncology/ cancer biology. Benedikt has authored articles in leading scientific publications, including Leukemia (Nature Publishing Group).